Edaravone joint ozagrel simvastatin treatment of acute cerebral infarction
Xiaoning Xu
Abstract
Xiaoning Xu
Abstract
Objective To observe the edaravone and ozagrel sodium,simvastatin treatment of acute ischemic stroke clinical efficacy.Methods The incidence of ACI in the 48 h in 72 cases patients were randomly divided into treatment group(36 cases) and control group(36 cases),clinical neurological impairment score and the clinical efficacy of contrast.Results The total effective rate(83.33%) was significantly higher than that(66.67%),two groups were no obvious adverse reactions.Conclusion Edaravone with ozagrel sodium,simvastatin treatment of acute cerebral infarction precise and safe,is worth the clinical promoted use.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the edaravone and ozagrel sodium,simvastatin treatment of acute ischemic stroke clinical efficacy.Methods The incidence of ACI in the 48 h in 72 cases patients were randomly divided into treatment group(36 cases) and control group(36 cases),clinical neurological impairment score and the clinical efficacy of contrast.Results The total effective rate(83.33%) was significantly higher than that(66.67%),two groups were no obvious adverse reactions.Conclusion Edaravone with ozagrel sodium,simvastatin treatment of acute cerebral infarction precise and safe,is worth the clinical promoted use.
Key concepts: Edaravone, Medicine, Simvastatin, Clinical efficacy, Anesthesia, Incidence (geometry), Adverse effect, Cerebral infarction